Healthcare for the disadvantaged

Healthcare for the disadvantaged

GSK is cooperating with Save the Children to improve basic healthcare services and access for ethnic minorities in Vietnam.
Pharma groups redouble patient-centric efforts

Pharma groups redouble patient-centric efforts

Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
GSK withdraws HIBERIX in Vietnam due to low demand

GSK withdraws HIBERIX in Vietnam due to low demand

GlaxoSmithKline (GSK) has decided to discontinue HIBERIX in Vietnam due to low medical demand for this vaccine and follow the Pharmaceutical Law.
Popular pharma products withdrawn by multinationals

Popular pharma products withdrawn by multinationals

Multinationals like Sanofi, GSK, Adamed Pharma, and Merck Sharp & Dohme have requested marketing authorisation withdrawal of some pharmaceuticals, with it being unclear if the quality of some popular items is an underlying issue.
Partnership signed to fight against antimicrobial resistance in Vietnam in 2021-2023 

Partnership signed to fight against antimicrobial resistance in Vietnam in 2021-2023 

The Medical Service Administration, the British Embassy, and the Representative Office of GSK will fight against antimicrobial resistance in 2021-2023.
Digitalisation prompts evolution of healthcare

Digitalisation prompts evolution of healthcare

Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
Replaced regulation to hit global drugmakers

Replaced regulation to hit global drugmakers

International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.
EU vaccine pooling plans picked apart

EU vaccine pooling plans picked apart

The EU proposal on the voluntary pooling of patents for coronavirus vaccines, treatments, and tests might be hard to reach, as global pharmaceutical giants stand reluctantly on the sidelines, making a low-cost, globally-available cure a dim prospect.
GSK supports global efforts in COVID-19 fight                        

GSK supports global efforts in COVID-19 fight                        

London-based GSK, the world's sixth-largest pharmaceutical company according to Forbes as of 2019, has taken action to support the global response to COVID-19.
US groups flock to ASEAN to further aid business interests

US groups flock to ASEAN to further aid business interests

Betting on Vietnam’s future growth potential driven by landmark free trade agreements, investors from both the United States and the ASEAN are releasing new plans to venture further into the lucrative local market, with healthcare being a heavy focus.
GSK supporting Vietnamese healthcare for 25 years

GSK supporting Vietnamese healthcare for 25 years

Investing in research and development (R&D) and introducing innovative solutions that suit Vietnam’s disease patterns and ensuring that patients have better access to essential medicines and vaccines have been part of GSK’s tireless efforts in Vietnam. Dan Millard, Chief representative of GSK Pte. in Vietnam, talked to VIR’s Hoang Anh about GSK’s 25-year journey of accompanying Vietnamese healthcare professionals in the prevention and treatment of diseases in Vietnam, helping Vietnamese people to do more, feel better, and live longer.
GSK prepares to grasp opportunities from EVFTA

GSK prepares to grasp opportunities from EVFTA

Daniel Millard, chief representative of GSK Vietnam, discussed with VIR’s Bich Thuy about the company’s preparations for the EVFTA.